-
Something wrong with this record ?
Endokrinní dysfunkce po léčbě checkpoint inhibitory
Bhavana Konda, Fadi Nabhan, Manisha H. Shah
Current Opinion in Endocrinology, Diabetes and Obesity (České vyd.).
2018 ;
6 (1) :
3-13.
Language Czech Country Czech Republic
Document type Case Reports, Review
Persistent link
https://www.medvik.cz/link/bmc18008805
- MeSH
- CTLA-4 Antigen antagonists & inhibitors MeSH
- B7-H1 Antigen MeSH
- Apoptosis immunology MeSH
- Hypophysitis etiology MeSH
- Immunotherapy adverse effects MeSH
- Combined Modality Therapy MeSH
- Middle Aged MeSH
- Humans MeSH
- Antibodies, Monoclonal adverse effects therapeutic use MeSH
- Neoplasms therapy MeSH
- Endocrine System Diseases * etiology MeSH
- Thyroid Diseases MeSH
- Antineoplastic Agents adverse effects therapeutic use MeSH
- Aged MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Publication type
- Case Reports MeSH
- Review MeSH
Citace: Konda B. et al.: Endocrine dysfunction following immune checkpoint inhibitor therapy. Curr Opin Endocrinol Diabetes Obes. 2017 Oct;24(5):337-347
Bibliography, etc.Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18008805
- 003
- CZ-PrNML
- 005
- 20181203131124.0
- 007
- ta
- 008
- 180322s2018 xr d f 000 0|cze||
- 009
- AR
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a cze
- 044 __
- $a xr
- 100 1_
- $a Konda, Bhavana $u Division of Medical Oncology, Department of Internal Medicine, Ohio State University and Arthur G. James Cancer Center, Columbus, Ohio, USA
- 245 10
- $a Endokrinní dysfunkce po léčbě checkpoint inhibitory / $c Bhavana Konda, Fadi Nabhan, Manisha H. Shah
- 500 __
- $a Citace: Konda B. et al.: Endocrine dysfunction following immune checkpoint inhibitor therapy. Curr Opin Endocrinol Diabetes Obes. 2017 Oct;24(5):337-347
- 504 __
- $a Literatura
- 650 _2
- $a monoklonální protilátky $x škodlivé účinky $x terapeutické užití $7 D000911
- 650 _2
- $a protinádorové látky $x škodlivé účinky $x terapeutické užití $7 D000970
- 650 _2
- $a apoptóza $x imunologie $7 D017209
- 650 _2
- $a antigeny CD274 $7 D060890
- 650 _2
- $a antigen CTLA-4 $x antagonisté a inhibitory $7 D060908
- 650 _2
- $a kombinovaná terapie $7 D003131
- 650 12
- $a nemoci endokrinního systému $x etiologie $7 D004700
- 650 _2
- $a hypofyzitida $x etiologie $7 D000072659
- 650 _2
- $a imunoterapie $x škodlivé účinky $7 D007167
- 650 _2
- $a nádory $x terapie $7 D009369
- 650 _2
- $a nemoci štítné žlázy $7 D013959
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a senioři $7 D000368
- 655 _2
- $a kazuistiky $7 D002363
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Nabhan, Fadi $u Division of Endocrinology, Diabetes, and Metabolism, Ohio State University and Arthur G. James Cancer Center, Columbus, Ohio, USA
- 700 1_
- $a Shah, Manisha H. $u Division of Medical Oncology, Department of Internal Medicine, Ohio State University and Arthur G. James Cancer Center, Columbus, Ohio, USA
- 773 0_
- $t Current Opinion in Endocrinology, Diabetes and Obesity (České vyd.) $x 1805-7101 $g Roč. 6, č. 1 (2018), s. 3-13 $w MED00180932
- 910 __
- $a ABA008 $b B 2667 $c 150 $y 4 $z 0
- 990 __
- $a 20180322093543 $b ABA008
- 991 __
- $a 20181203131236 $b ABA008
- 999 __
- $a ok $b bmc $g 1284468 $s 1005596
- BAS __
- $a 3
- BMC __
- $a 2018 $b 6 $c 1 $d 3-13 $i 1805-7101 $m Current Opinion in Endocrinology, Diabetes and Obesity (České vyd.) $n Curr. Opin. Endocrinol. Diabetes Obes. (Čes. vyd.) $x MED00180932
- LZP __
- $c NLK182 $d 20181203 $a NLK 2018-05/mk
